nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2C19—urine—bipolar disorder	0.0231	0.0929	CbGeAlD
Brompheniramine—CYP2C9—urine—bipolar disorder	0.0179	0.072	CbGeAlD
Brompheniramine—CYP2E1—urine—bipolar disorder	0.017	0.0682	CbGeAlD
Brompheniramine—CYP3A4—urine—bipolar disorder	0.0137	0.0549	CbGeAlD
Brompheniramine—CYP2D6—urine—bipolar disorder	0.0134	0.054	CbGeAlD
Brompheniramine—CYP2C19—blood plasma—bipolar disorder	0.0121	0.0485	CbGeAlD
Brompheniramine—CYP2C8—blood plasma—bipolar disorder	0.0105	0.0423	CbGeAlD
Brompheniramine—CYP2B6—blood plasma—bipolar disorder	0.00944	0.0379	CbGeAlD
Brompheniramine—CYP2C9—blood plasma—bipolar disorder	0.00934	0.0376	CbGeAlD
Brompheniramine—CYP2E1—blood plasma—bipolar disorder	0.00886	0.0356	CbGeAlD
Brompheniramine—CHRM4—nervous system—bipolar disorder	0.00882	0.0355	CbGeAlD
Brompheniramine—CYP3A4—blood plasma—bipolar disorder	0.00713	0.0287	CbGeAlD
Brompheniramine—CYP2D6—blood plasma—bipolar disorder	0.00701	0.0282	CbGeAlD
Brompheniramine—Captodiame—DRD3—bipolar disorder	0.00691	0.217	CrCbGaD
Brompheniramine—CHRM5—nervous system—bipolar disorder	0.0069	0.0277	CbGeAlD
Brompheniramine—CHRM4—brain—bipolar disorder	0.00675	0.0271	CbGeAlD
Brompheniramine—Orphenadrine—GRIN1—bipolar disorder	0.00641	0.201	CrCbGaD
Brompheniramine—Captodiame—HTR2C—bipolar disorder	0.0058	0.182	CrCbGaD
Brompheniramine—CHRM5—brain—bipolar disorder	0.00527	0.0212	CbGeAlD
Brompheniramine—CYP2B6—adrenal cortex—bipolar disorder	0.00479	0.0193	CbGeAlD
Brompheniramine—CHRM2—nervous system—bipolar disorder	0.00473	0.019	CbGeAlD
Brompheniramine—CHRM3—thyroid gland—bipolar disorder	0.00459	0.0184	CbGeAlD
Brompheniramine—CHRM1—nervous system—bipolar disorder	0.00431	0.0173	CbGeAlD
Brompheniramine—CHRM3—nervous system—bipolar disorder	0.00386	0.0155	CbGeAlD
Brompheniramine—CHRM2—brain—bipolar disorder	0.00362	0.0146	CbGeAlD
Brompheniramine—KCNH2—nervous system—bipolar disorder	0.00342	0.0137	CbGeAlD
Brompheniramine—CHRM1—brain—bipolar disorder	0.00329	0.0132	CbGeAlD
Brompheniramine—KCNH2—cerebellum—bipolar disorder	0.00322	0.0129	CbGeAlD
Brompheniramine—CYP2E1—thyroid gland—bipolar disorder	0.00313	0.0126	CbGeAlD
Brompheniramine—CHRM3—brain—bipolar disorder	0.00295	0.0119	CbGeAlD
Brompheniramine—Chlorphenamine—SLC6A3—bipolar disorder	0.0029	0.091	CrCbGaD
Brompheniramine—CYP2B6—nervous system—bipolar disorder	0.00281	0.0113	CbGeAlD
Brompheniramine—HRH1—nervous system—bipolar disorder	0.00274	0.011	CbGeAlD
Brompheniramine—CYP2E1—nervous system—bipolar disorder	0.00263	0.0106	CbGeAlD
Brompheniramine—KCNH2—brain—bipolar disorder	0.00261	0.0105	CbGeAlD
Brompheniramine—CYP2E1—cerebellum—bipolar disorder	0.00248	0.00997	CbGeAlD
Brompheniramine—CYP2C8—brain—bipolar disorder	0.00239	0.00962	CbGeAlD
Brompheniramine—Chlorphenamine—SLC6A4—bipolar disorder	0.00217	0.068	CrCbGaD
Brompheniramine—CYP2B6—brain—bipolar disorder	0.00215	0.00863	CbGeAlD
Brompheniramine—CYP3A4—nervous system—bipolar disorder	0.00212	0.00852	CbGeAlD
Brompheniramine—Promazine—DRD4—bipolar disorder	0.00211	0.0664	CrCbGaD
Brompheniramine—HRH1—brain—bipolar disorder	0.00209	0.00842	CbGeAlD
Brompheniramine—CYP2D6—nervous system—bipolar disorder	0.00209	0.00838	CbGeAlD
Brompheniramine—CYP2E1—brain—bipolar disorder	0.00201	0.00809	CbGeAlD
Brompheniramine—CYP2D6—cerebellum—bipolar disorder	0.00196	0.00789	CbGeAlD
Brompheniramine—Promazine—DRD1—bipolar disorder	0.00179	0.0562	CrCbGaD
Brompheniramine—CYP2D6—brain—bipolar disorder	0.00159	0.00641	CbGeAlD
Brompheniramine—Promazine—HTR2C—bipolar disorder	0.00153	0.0481	CrCbGaD
Brompheniramine—Promazine—DRD2—bipolar disorder	0.00126	0.0396	CrCbGaD
Brompheniramine—Promazine—HTR2A—bipolar disorder	0.000975	0.0306	CrCbGaD
Brompheniramine—CYP2C9—Metabolism—NR1D1—bipolar disorder	0.000144	0.0002	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—DRD4—bipolar disorder	0.000144	0.0002	CbGpPWpGaD
Brompheniramine—CYP3A4—Biological oxidations—POMC—bipolar disorder	0.000144	0.0002	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3C2A—bipolar disorder	0.000143	0.000199	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TRPC3—bipolar disorder	0.000143	0.000199	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CLOCK—bipolar disorder	0.000142	0.000197	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ADCY2—bipolar disorder	0.000141	0.000196	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TCF7L2—bipolar disorder	0.000141	0.000195	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—DRD2—bipolar disorder	0.00014	0.000194	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—POMC—bipolar disorder	0.000139	0.000194	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NCAN—bipolar disorder	0.000139	0.000193	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CLOCK—bipolar disorder	0.000139	0.000193	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADM—bipolar disorder	0.000138	0.000192	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADM—bipolar disorder	0.000138	0.000192	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—TSHB—bipolar disorder	0.000138	0.000192	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—TPH2—bipolar disorder	0.000138	0.000192	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CACNB2—bipolar disorder	0.000138	0.000192	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NCAN—bipolar disorder	0.000138	0.000191	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADM—bipolar disorder	0.000138	0.000191	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADM—bipolar disorder	0.000136	0.000189	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—SLC5A3—bipolar disorder	0.000136	0.000189	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—DPYD—bipolar disorder	0.000136	0.000189	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ADCY2—bipolar disorder	0.000135	0.000188	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—TSHB—bipolar disorder	0.000135	0.000188	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—TPH2—bipolar disorder	0.000135	0.000188	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CACNB2—bipolar disorder	0.000135	0.000188	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TSHB—bipolar disorder	0.000135	0.000188	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PDE4B—bipolar disorder	0.000135	0.000188	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TACR1—bipolar disorder	0.000135	0.000188	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—SLC5A3—bipolar disorder	0.000135	0.000188	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TCF7L2—bipolar disorder	0.000135	0.000187	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TSHB—bipolar disorder	0.000135	0.000187	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TACR1—bipolar disorder	0.000135	0.000187	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PDE4B—bipolar disorder	0.000135	0.000187	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TSHB—bipolar disorder	0.000134	0.000186	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PDE4B—bipolar disorder	0.000134	0.000186	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TACR1—bipolar disorder	0.000134	0.000186	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—DRD2—bipolar disorder	0.000134	0.000186	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—DPYD—bipolar disorder	0.000133	0.000185	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PDE4B—bipolar disorder	0.000133	0.000185	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TSHB—bipolar disorder	0.000133	0.000185	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TACR1—bipolar disorder	0.000133	0.000185	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—POMC—bipolar disorder	0.000132	0.000184	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—IMPA1—bipolar disorder	0.000128	0.000178	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—SNAP25—bipolar disorder	0.000128	0.000178	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—POMC—bipolar disorder	0.000127	0.000176	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NTRK1—bipolar disorder	0.000126	0.000176	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CACNA1C—bipolar disorder	0.000126	0.000175	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CACNA1C—bipolar disorder	0.000124	0.000172	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000123	0.000171	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000123	0.000171	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3C2A—bipolar disorder	0.000123	0.000171	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—S100B—bipolar disorder	0.000123	0.000171	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—HTR2A—bipolar disorder	0.000123	0.00017	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—HTR2A—bipolar disorder	0.000121	0.000169	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NTRK1—bipolar disorder	0.000121	0.000168	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3C2A—bipolar disorder	0.00012	0.000167	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CLOCK—bipolar disorder	0.00012	0.000167	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—S100B—bipolar disorder	0.000118	0.000164	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—TSHB—bipolar disorder	0.000117	0.000162	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CACNB2—bipolar disorder	0.000117	0.000162	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—TPH2—bipolar disorder	0.000117	0.000162	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—DPYD—bipolar disorder	0.000115	0.00016	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ADCY2—bipolar disorder	0.000113	0.000158	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	0.000112	0.000156	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HTR1A—bipolar disorder	0.000112	0.000155	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	0.000112	0.000155	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	0.000111	0.000155	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HTR2A—bipolar disorder	0.000111	0.000155	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HTR1A—bipolar disorder	0.000111	0.000154	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—SNAP25—bipolar disorder	0.00011	0.000153	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HTR2A—bipolar disorder	0.00011	0.000153	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TAC1—bipolar disorder	0.00011	0.000153	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HTR1A—bipolar disorder	0.00011	0.000153	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TAC1—bipolar disorder	0.00011	0.000152	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TAC1—bipolar disorder	0.000109	0.000152	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NDUFV2—bipolar disorder	0.000109	0.000152	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NRG1—bipolar disorder	0.000108	0.000151	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TAC1—bipolar disorder	0.000108	0.00015	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—SNAP25—bipolar disorder	0.000108	0.00015	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DRD1—bipolar disorder	0.000108	0.00015	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HTR2C—bipolar disorder	0.000108	0.00015	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	0.000108	0.000149	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DRD1—bipolar disorder	0.000108	0.000149	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HTR2C—bipolar disorder	0.000107	0.000149	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DRD1—bipolar disorder	0.000107	0.000149	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CLOCK—bipolar disorder	0.000107	0.000149	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CACNA1C—bipolar disorder	0.000107	0.000148	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DRD1—bipolar disorder	0.000106	0.000148	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HTR2C—bipolar disorder	0.000106	0.000148	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKR1C4—bipolar disorder	0.000106	0.000147	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NTRK2—bipolar disorder	0.000105	0.000146	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	0.000105	0.000145	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DRD3—bipolar disorder	0.000104	0.000145	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NTRK2—bipolar disorder	0.000104	0.000145	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—TPH2—bipolar disorder	0.000104	0.000145	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—TSHB—bipolar disorder	0.000104	0.000145	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CACNB2—bipolar disorder	0.000104	0.000145	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DRD3—bipolar disorder	0.000104	0.000145	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3C2A—bipolar disorder	0.000104	0.000145	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	0.000104	0.000145	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NRG1—bipolar disorder	0.000104	0.000144	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DRD3—bipolar disorder	0.000104	0.000144	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	0.000104	0.000144	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GSK3A—bipolar disorder	0.000103	0.000144	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NTRK2—bipolar disorder	0.000103	0.000144	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DRD3—bipolar disorder	0.000103	0.000143	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000103	0.000143	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—DPYD—bipolar disorder	0.000103	0.000143	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GSK3A—bipolar disorder	0.000102	0.000142	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DRD4—bipolar disorder	0.000101	0.000141	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DRD4—bipolar disorder	0.000101	0.000141	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DRD4—bipolar disorder	0.000101	0.00014	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DRD4—bipolar disorder	9.98e-05	0.000139	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	9.85e-05	0.000137	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CLOCK—bipolar disorder	9.84e-05	0.000137	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	9.82e-05	0.000136	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	9.79e-05	0.000136	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HTR2A—bipolar disorder	9.78e-05	0.000136	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ADCY2—bipolar disorder	9.76e-05	0.000136	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CLOCK—bipolar disorder	9.75e-05	0.000136	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—COMT—bipolar disorder	9.71e-05	0.000135	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	9.69e-05	0.000135	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—MAOA—bipolar disorder	9.65e-05	0.000134	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—TPH2—bipolar disorder	9.59e-05	0.000133	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CACNB2—bipolar disorder	9.59e-05	0.000133	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—TSHB—bipolar disorder	9.59e-05	0.000133	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ADCY2—bipolar disorder	9.56e-05	0.000133	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	9.55e-05	0.000133	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CACNA1C—bipolar disorder	9.53e-05	0.000133	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	9.52e-05	0.000132	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	9.51e-05	0.000132	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—TSHB—bipolar disorder	9.5e-05	0.000132	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—TPH2—bipolar disorder	9.5e-05	0.000132	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CACNB2—bipolar disorder	9.5e-05	0.000132	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NR1D1—bipolar disorder	9.49e-05	0.000132	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	9.49e-05	0.000132	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	9.48e-05	0.000132	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	9.45e-05	0.000131	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DRD2—bipolar disorder	9.45e-05	0.000131	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—DPYD—bipolar disorder	9.43e-05	0.000131	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DRD2—bipolar disorder	9.42e-05	0.000131	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	9.39e-05	0.000131	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DRD2—bipolar disorder	9.39e-05	0.00013	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HTR2A—bipolar disorder	9.37e-05	0.00013	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	9.36e-05	0.00013	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—DPYD—bipolar disorder	9.35e-05	0.00013	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—SNAP25—bipolar disorder	9.34e-05	0.00013	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DRD2—bipolar disorder	9.3e-05	0.000129	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	9.29e-05	0.000129	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	9.17e-05	0.000127	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NCAN—bipolar disorder	9.08e-05	0.000126	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—POMC—bipolar disorder	8.95e-05	0.000124	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—POMC—bipolar disorder	8.92e-05	0.000124	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC5A3—bipolar disorder	8.9e-05	0.000124	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—POMC—bipolar disorder	8.89e-05	0.000124	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—POMC—bipolar disorder	8.8e-05	0.000122	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	8.77e-05	0.000122	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CACNA1C—bipolar disorder	8.69e-05	0.000121	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	8.55e-05	0.000119	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	8.55e-05	0.000119	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	8.53e-05	0.000119	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	8.5e-05	0.000118	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	8.47e-05	0.000118	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	8.42e-05	0.000117	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	8.36e-05	0.000116	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—COMT—bipolar disorder	8.36e-05	0.000116	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—SNAP25—bipolar disorder	8.33e-05	0.000116	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—S100B—bipolar disorder	8.32e-05	0.000116	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—MAOA—bipolar disorder	8.3e-05	0.000115	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—S100B—bipolar disorder	8.29e-05	0.000115	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—S100B—bipolar disorder	8.26e-05	0.000115	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ADCY2—bipolar disorder	8.26e-05	0.000115	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—COMT—bipolar disorder	8.19e-05	0.000114	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—S100B—bipolar disorder	8.18e-05	0.000114	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—MAOA—bipolar disorder	8.13e-05	0.000113	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—GSK3B—bipolar disorder	7.88e-05	0.000109	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—MTHFR—bipolar disorder	7.85e-05	0.000109	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—POMC—bipolar disorder	7.81e-05	0.000109	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—INS—bipolar disorder	7.77e-05	0.000108	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—SNAP25—bipolar disorder	7.66e-05	0.000107	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—SNAP25—bipolar disorder	7.6e-05	0.000106	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—GSK3B—bipolar disorder	7.54e-05	0.000105	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—POMC—bipolar disorder	7.48e-05	0.000104	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—INS—bipolar disorder	7.44e-05	0.000103	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ADCY2—bipolar disorder	7.37e-05	0.000103	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NRG1—bipolar disorder	7.34e-05	0.000102	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NRG1—bipolar disorder	7.32e-05	0.000102	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NRG1—bipolar disorder	7.29e-05	0.000101	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NRG1—bipolar disorder	7.22e-05	0.0001	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—COMT—bipolar disorder	7.08e-05	9.83e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MAOA—bipolar disorder	7.03e-05	9.77e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ADCY2—bipolar disorder	6.78e-05	9.43e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—MTHFR—bipolar disorder	6.76e-05	9.39e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ADCY2—bipolar disorder	6.72e-05	9.35e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	6.62e-05	9.2e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—MTHFR—bipolar disorder	6.62e-05	9.2e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	6.6e-05	9.17e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	6.58e-05	9.14e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	6.51e-05	9.05e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CLOCK—bipolar disorder	6.43e-05	8.94e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—COMT—bipolar disorder	6.32e-05	8.78e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—POMC—bipolar disorder	6.28e-05	8.73e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MAOA—bipolar disorder	6.27e-05	8.72e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CACNB2—bipolar disorder	6.27e-05	8.71e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TPH2—bipolar disorder	6.27e-05	8.71e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TSHB—bipolar disorder	6.27e-05	8.71e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—INS—bipolar disorder	6.25e-05	8.68e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—DPYD—bipolar disorder	6.17e-05	8.57e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—COMT—bipolar disorder	5.81e-05	8.07e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MAOA—bipolar disorder	5.77e-05	8.02e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—COMT—bipolar disorder	5.76e-05	8e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CACNA1C—bipolar disorder	5.73e-05	7.97e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MTHFR—bipolar disorder	5.72e-05	7.95e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MAOA—bipolar disorder	5.72e-05	7.95e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	5.59e-05	7.77e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—POMC—bipolar disorder	5.4e-05	7.51e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—INS—bipolar disorder	5.37e-05	7.47e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	5.33e-05	7.41e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	5.31e-05	7.38e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	5.29e-05	7.36e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—POMC—bipolar disorder	5.29e-05	7.36e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—POMC—bipolar disorder	5.28e-05	7.35e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—POMC—bipolar disorder	5.27e-05	7.32e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—INS—bipolar disorder	5.26e-05	7.31e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—INS—bipolar disorder	5.26e-05	7.31e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—POMC—bipolar disorder	5.25e-05	7.3e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	5.24e-05	7.29e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—INS—bipolar disorder	5.24e-05	7.28e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—INS—bipolar disorder	5.22e-05	7.26e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—POMC—bipolar disorder	5.2e-05	7.23e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—INS—bipolar disorder	5.17e-05	7.19e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MTHFR—bipolar disorder	5.1e-05	7.1e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SNAP25—bipolar disorder	5.01e-05	6.97e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTHFR—bipolar disorder	4.7e-05	6.53e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—bipolar disorder	4.65e-05	6.47e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—POMC—bipolar disorder	4.57e-05	6.36e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—INS—bipolar disorder	4.55e-05	6.32e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADCY2—bipolar disorder	4.43e-05	6.16e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—POMC—bipolar disorder	4.08e-05	5.67e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—INS—bipolar disorder	4.06e-05	5.64e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—COMT—bipolar disorder	3.8e-05	5.28e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MAOA—bipolar disorder	3.77e-05	5.24e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—POMC—bipolar disorder	3.75e-05	5.22e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—INS—bipolar disorder	3.73e-05	5.19e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—POMC—bipolar disorder	3.72e-05	5.17e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—INS—bipolar disorder	3.7e-05	5.15e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—bipolar disorder	3.07e-05	4.27e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—POMC—bipolar disorder	2.46e-05	3.41e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—INS—bipolar disorder	2.44e-05	3.39e-05	CbGpPWpGaD
